P001. Comparison of in vivo T cell homing to the inflamed gut with the etrolizumab surrogate antibody FIB504 and vedolizumab in a humanised mouse model | Zendy

AI Assistant Blog Pricing

P001. Comparison of in vivo T cell homing to the inflamed gut with the etrolizumab surrogate antibody FIB504 and vedolizumab in a humanised mouse model

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.